CAS RN: 5260-20-8
2,5-DIAZABICYCLO[2.2.1]HEPTANE, DIHYDROCHLORIDE
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: >97%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 5260-20-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
| 0.25g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
| 1g |
>97% |
1
In Stock
|
Shenzhen |
Inquiry |
5260-20-8 / (1S,4S)-2,5-diazabicyclo[2.2.1]heptane;dihydrochloride
Standard CAS: 5260-20-8
Multi CAS: Yes
Basic Information
CAS
5260-20-8
Multi CAS
Yes
Molecular Formula
C5H12CL2N2
Molecular Weight
171.070000
Exact Mass
170.037754
InChI
InChI=1S/C5H10N2.2ClH/c1-4-2-6-5(1)3-7-4;;/h4-7H,1-3H2;2*1H/t4-,5-;;/m0../s1
InChIKey
PIDOCGDMKRSJMT-RSLHMRQOSA-N
Computed Properties
Structural Parameters
Heavy atom count
9
Fraction Csp3
1
H-bond acceptors
2
H-bond donors
2
Molar refractivity
42.69
TPSA
24.06
LogP / Solubility
WLOGP
0.16
MLOGP
0.14
XLogP3
0.16
Consensus LogP
0.15
Log S (ESOL)
-1
Class (ESOL)
Soluble
Log S (Ali)
-1.08
Class (Ali)
Soluble
Log S (SILICOS-IT)
-0.91
Class (SILICOS-IT)
Very soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.65
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4.5